Predictive Biomarkers of Dicycloplatin Resistance or Susceptibility in Prostate Cancer

BACKGROUND: Prostate cancer (PCa) is among the leading causes of cancer mortality. Dicycloplatin is a newer generation platinum-based drug that has less side effects than cisplatin and carboplatin. However, its effects in PCa is mixed due to lack of appropriate stratifying biomarkers. Aiming to sear...

Descripción completa

Detalles Bibliográficos
Autores principales: Liu, Minglu, Zhou, Xiaoyu, Liu, Jun, Lu, Chelong, Zhang, Guoqing, Zhang, Jing, Jiao, Shunchang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Genetics
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8353331/
https://www.ncbi.nlm.nih.gov/pubmed/34386035
http://dx.doi.org/10.3389/fgene.2021.669605

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8353331/
https://www.ncbi.nlm.nih.gov/pubmed/34386035
http://dx.doi.org/10.3389/fgene.2021.669605

Ejemplares similares